Pharmicell (Korea) Today
| 005690 Stock | 8,790 280.00 3.29% |
Performance20 of 100
| Odds Of DistressLess than 24
|
Pharmicell is trading at 8790.00 as of the 7th of January 2025, a 3.29 percent up since the beginning of the trading day. The stock's open price was 8510.0. Pharmicell has about a 24 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat solid performance during the last 90 days. The performance scores are derived for the period starting the 8th of December 2024 and ending today, the 7th of January 2025. Click here to learn more.
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Pharmicell Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Pharmicell's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Pharmicell or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
Pharmicell (005690) is traded on Korea Stock Exchange in Korea and employs 7 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 613.84 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pharmicell's market, we take the total number of its shares issued and multiply it by Pharmicell's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Pharmicell operates under Biotechnology sector and is part of Health Care industry. The entity has 60 M outstanding shares.
Pharmicell generates negative cash flow from operations
Check Pharmicell Probability Of Bankruptcy
Ownership AllocationPharmicell owns a total of 60 Million outstanding shares. Pharmicell holds 9.59 pct. of its outstanding shares held by insiders and 13.0 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Pharmicell Ownership Details
Pharmicell Risk Profiles
Although Pharmicell's alpha and beta are two of the key measurements used to evaluate Pharmicell's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.46 | |||
| Semi Deviation | 2.09 | |||
| Standard Deviation | 3.53 | |||
| Variance | 12.46 |
Pharmicell Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Pharmicell without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
Pharmicell Corporate Directors
| HyunSoo Kim | Chief Director | Profile | |
| WoonSung Baek | Managing Director | Profile | |
| ShiYoung Jang | Managing Director | Profile | |
| Yongman Kim | Managing Director | Profile |
Other Information on Investing in Pharmicell Stock
Pharmicell financial ratios help investors to determine whether Pharmicell Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmicell with respect to the benefits of owning Pharmicell security.